Adarza BioSystems picks up $17 mln in RiverVest-led round
Rochester, New York and St. Louis, Missouri-based Adarza BioSystems Inc, a developer of label-free biosensor assays and instruments, has raised $17 million in Series C funding. RiverVest Venture Partners led the round.
23 January 2017•1 min read
